Danaher lifts quarterly profit and raises 2026 adjusted EPS outlook
Danaher's third-quarter net income rose sharply and the lab equipment maker raised its adjusted earnings growth projection for 2026. Revenue came in just below forecasts.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
According to Dow Jones Newswires, Danaher, a Washington, DC maker of laboratory equipment, reported third-quarter net income of $1.24 billion, or $1.75 a share, for the quarter ended September 25, versus $908 million, or $1.27 a share, a year earlier. Excluding certain one-off items, adjusted earnings reached $2.11 a share, above the $1.91 average analyst estimate compiled by FactSet.
Revenue grew 8.3% to $6.55 billion, slightly below the Wall Street average of $6.56 billion. For the fourth quarter, the company targets core revenue growth, excluding respiratory revenue, of 4% to 5%. For 2026, Danaher raised its adjusted earnings forecast to $8.57–$8.62 a share from $8.45–$8.60.
why it matters
The results from the life sciences and diagnostics company show profit beating expectations while revenue landed roughly in line. A raised full-year outlook matters for investors in healthcare and instrument makers.
market impact
Danaher and life sciences peers: profit beat and higher guidance support the stock
tags
instruments
sources
- Danaher 3Q Net Up Sharply as Company Boosts 2026 Adj EPS View — Dow Jones Newswires, 21 October 2026 at 10:17 UTC
- Danaher 3Q Net Up Sharply as Company Boosts 2026 Adjusted EPS View — Dow Jones Newswires, 21 October 2026 at 10:32 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗